State Of Wyoming Bio Atla, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.38 - $18.78 $192 - $826	-44 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$19.0 - $30.95 $38 - $61	-2 Reduced 4.35%	44 $1,000
Q3 2021 Feb 11, 2022	SELL	$29.44 - $43.74 $706 - $1,049	-24 Reduced 34.29%	46 $1,000
Q2 2021 Feb 11, 2022	BUY	$38.07 - $56.17 $1,408 - $2,078	37 Added 112.12%	70 $3,000
Q1 2021 Feb 08, 2022	BUY	$32.41 - $70.91 $1,069 - $2,340	33 New	33 $2,000

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.